Notice Information
Notice Title
BCG Vaccine & TB Skin Test (2027)
Notice Description
The provision of Bacillus Calmette-Guerin (BCG) vaccine and intradermal diagnostic skin test for the detection of Mycobacterium tuberculosis infection. Deliveries will be required up to a period of 2 years, with an option to extend for up to an additional 24 months. Information about volumes for each lot is included in the Invitation to Offer documents.
Lot Information
Bacillus Calmette-Guerin (BCG) vaccine
BCG vaccine indicated for the prevention of Tuberculosis
Renewal: There is an option for the Authority to extend for a period or periods up to an additional 24 months
Intradermal diagnostic skin test for the detection of Mycobacterium tuberculosisAn intradermal diagnostic skin test, indicated for the detection of Mycobacterium tuberculosis infection
Renewal: There is an option for the Authority to extend for a period or periods up to an additional 24 months
Planning Information
The UK Health Security Agency sent a short pre-market engagement questionnaire to known UK suppliers of tuberculosis intradermal skin tests to understand their capability to meet the requirements for the intradermal diagnostic skin test for the detection of Mycobacterium tuberculosis infection. Insights collected primarily focused on product specification, shelf life and supply chain to better understand the current market landscape.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-068de0
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/043013-2026
- Current Stage
- Tender
- All Stages
- Planning, Tender
Procurement Classification
- Notice Type
- UK4 - Tender Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Competitive flexible procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33651600 - Vaccines
33694000 - Diagnostic agents
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 11 May 20261 months ago
- Submission Deadline
- 15 Jun 2026Expired
- Future Notice Date
- 6 May 2026Expired
- Award Date
- Not specified
- Contract Period
- 31 Mar 2027 - 31 Mar 2029 2-3 years
- Recurrence
- 2026-10-20
Notice Status
- Tender Status
- Active
- Lots Status
- Active
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE ACTING AS PART OF THE CROWN THROUGH UK HEALTH SECURITY AGENCY
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- LONDON
- Postcode
- E14 4PU
- Post Town
- East London
- Country
- England
-
- Major Region (ITL 1)
- TLI London
- Basic Region (ITL 2)
- TLI4 Inner London - East
- Small Region (ITL 3)
- TLI42 Tower Hamlets
- Delivery Location
- Not specified
-
- Local Authority
- Tower Hamlets
- Electoral Ward
- Canary Wharf
- Westminster Constituency
- Poplar and Limehouse
Further Information
Notice Documents
-
https://www.find-tender.service.gov.uk/Notice/043013-2026
11th May 2026 - Tender notice on Find a Tender -
https://www.find-tender.service.gov.uk/Notice/039130-2026
29th April 2026 - Preliminary market engagement notice on Find a Tender
Open Contracting Data Standard (OCDS)
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-068de0-2026-05-11T13:48:43+01:00",
"date": "2026-05-11T13:48:43+01:00",
"ocid": "ocds-h6vhtk-068de0",
"initiationType": "tender",
"parties": [
{
"id": "GB-PPON-PBMQ-7576-DVGW",
"name": "Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency",
"identifier": {
"scheme": "GB-PPON",
"id": "PBMQ-7576-DVGW"
},
"address": {
"streetAddress": "10 South Colonnade",
"locality": "London",
"postalCode": "E14 4PU",
"country": "GB",
"countryName": "United Kingdom",
"region": "UKI42"
},
"contactPoint": {
"name": "VMC Vaccines",
"email": "vmc.vaccines@ukhsa.gov.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.gov.uk/government/organisations/uk-health-security-agency",
"classifications": [
{
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE",
"description": "Public authority - central government"
}
]
}
}
],
"buyer": {
"id": "GB-PPON-PBMQ-7576-DVGW",
"name": "Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency"
},
"planning": {
"milestones": [
{
"id": "engagement",
"type": "engagement",
"description": "The UK Health Security Agency sent a short pre-market engagement questionnaire to known UK suppliers of tuberculosis intradermal skin tests to understand their capability to meet the requirements for the intradermal diagnostic skin test for the detection of Mycobacterium tuberculosis infection. Insights collected primarily focused on product specification, shelf life and supply chain to better understand the current market landscape.",
"dateMet": "2026-03-13T00:00:00Z",
"status": "met"
}
],
"documents": [
{
"id": "039130-2026",
"documentType": "marketEngagementNotice",
"noticeType": "UK2",
"description": "Preliminary market engagement notice on Find a Tender",
"url": "https://www.find-tender.service.gov.uk/Notice/039130-2026",
"datePublished": "2026-04-29T12:21:11+01:00",
"format": "text/html"
}
]
},
"tender": {
"id": "C426981",
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"title": "BCG Vaccine & TB Skin Test (2027)",
"description": "The provision of Bacillus Calmette-Guerin (BCG) vaccine and intradermal diagnostic skin test for the detection of Mycobacterium tuberculosis infection. Deliveries will be required up to a period of 2 years, with an option to extend for up to an additional 24 months. Information about volumes for each lot is included in the Invitation to Offer documents.",
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33651600",
"description": "Vaccines"
}
],
"deliveryAddresses": [
{
"region": "UK",
"country": "GB",
"countryName": "United Kingdom"
},
{
"region": "UK",
"country": "GB",
"countryName": "United Kingdom"
}
],
"relatedLot": "1"
},
{
"id": "2",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33694000",
"description": "Diagnostic agents"
}
],
"deliveryAddresses": [
{
"region": "UK",
"country": "GB",
"countryName": "United Kingdom"
}
],
"relatedLot": "2"
}
],
"value": {
"amountGross": 0,
"amount": 0,
"currency": "GBP"
},
"mainProcurementCategory": "goods",
"aboveThreshold": true,
"lots": [
{
"id": "1",
"contractPeriod": {
"startDate": "2027-04-01T00:00:00+01:00",
"endDate": "2029-03-31T23:59:59+01:00",
"maxExtentDate": "2031-03-31T23:59:59+01:00"
},
"hasRenewal": true,
"status": "active",
"title": "Bacillus Calmette-Guerin (BCG) vaccine",
"description": "BCG vaccine indicated for the prevention of Tuberculosis",
"value": {
"amountGross": 0,
"amount": 0,
"currency": "GBP"
},
"awardCriteria": {
"weightingDescription": "Full details of the award criteria can be found in the tender documentation.",
"criteria": [
{
"type": "quality",
"name": "Quality criterion",
"description": "Comparison with specification"
},
{
"type": "quality",
"name": "Quality criterion",
"description": "Risk to programme delivery"
},
{
"type": "quality",
"name": "Quality criterion",
"description": "Social value"
},
{
"type": "cost",
"name": "Cost criterion",
"description": "Benchmark price"
},
{
"type": "cost",
"name": "Cost criterion",
"description": "Product price"
},
{
"type": "cost",
"name": "Cost criterion",
"description": "Additional costs"
},
{
"type": "cost",
"name": "Cost criterion",
"description": "Storage costs"
},
{
"type": "quality",
"name": "Quality critierion",
"description": "Comparison with specification"
},
{
"type": "quality",
"name": "Quality criterion",
"description": "Risk to programme delivery"
},
{
"type": "quality",
"name": "Quality criterion",
"description": "Social value"
},
{
"type": "cost",
"name": "Cost criterion",
"description": "Benchmark price"
},
{
"type": "cost",
"name": "Cost criterion",
"description": "Product price"
},
{
"type": "cost",
"name": "Cost criterion",
"description": "Additional costs"
},
{
"type": "cost",
"name": "Cost criterion",
"description": "Storage costs"
}
]
},
"renewal": {
"description": "There is an option for the Authority to extend for a period or periods up to an additional 24 months"
}
},
{
"id": "2",
"title": "Intradermal diagnostic skin test for the detection of Mycobacterium tuberculosis",
"description": "An intradermal diagnostic skin test, indicated for the detection of Mycobacterium tuberculosis infection",
"status": "active",
"value": {
"amountGross": 0,
"amount": 0,
"currency": "GBP"
},
"awardCriteria": {
"weightingDescription": "Full details of the award criteria can be found in the tender documentation.",
"criteria": [
{
"type": "quality",
"name": "Quality criterion",
"description": "Comparison with specification"
},
{
"type": "quality",
"name": "Quality criterion",
"description": "Risk to programme delivery"
},
{
"type": "quality",
"name": "Quality criterion",
"description": "Social value"
},
{
"type": "cost",
"name": "Cost criterion",
"description": "Benchmark price"
},
{
"type": "cost",
"name": "Cost criterion",
"description": "Product price"
},
{
"type": "cost",
"name": "Cost criterion",
"description": "Additional costs"
},
{
"type": "cost",
"name": "Cost criterion",
"description": "Storage costs"
},
{
"type": "quality",
"name": "Quality critierion",
"description": "Comparison with specification"
},
{
"type": "quality",
"name": "Quality criterion",
"description": "Risk to programme delivery"
},
{
"type": "quality",
"name": "Quality criterion",
"description": "Social value"
},
{
"type": "cost",
"name": "Cost criterion",
"description": "Benchmark price"
},
{
"type": "cost",
"name": "Cost criterion",
"description": "Product price"
},
{
"type": "cost",
"name": "Cost criterion",
"description": "Additional costs"
},
{
"type": "cost",
"name": "Cost criterion",
"description": "Storage costs"
}
]
},
"contractPeriod": {
"startDate": "2027-04-01T00:00:00+01:00",
"endDate": "2029-03-31T23:59:59+01:00",
"maxExtentDate": "2031-03-31T23:59:59+01:00"
},
"hasRenewal": true,
"renewal": {
"description": "There is an option for the Authority to extend for a period or periods up to an additional 24 months"
}
}
],
"communication": {
"futureNoticeDate": "2026-05-06T23:59:59+01:00"
},
"status": "active",
"procurementMethod": "open",
"procurementMethodDetails": "Competitive flexible procedure",
"procedure": {
"features": "This procurement is conducted in accordance with the Procurement Act 2023 using a competitive flexible procedure. Initial Offers will be evaluated by the Authority against the award criteria set out in the Invitation to Offer. * Lot 1: Offerors for Lot 1 who pass the award criteria will proceed to the negotiation stage if a negotiation stage is required. A negotiation stage will be used for Lot 1 if any elements of the Offer are unclear or do not meet the Specification or otherwise require discussion using the subjects for negotiation set out * Lot 2: Offerors who pass the award criteria outlined will proceed to the negotiation stage for Lot 2. The Authority may choose to negotiate different aspects of the Offers with different Offerors, provided that the Authority does so in a manner consistent with the principles set out in section 12 of the Procurement Act 2023, including the duty to act transparently and to treat suppliers fairly. After the Negotiation Stage has closed, the Authority will invite final Offers in the form of a resubmission. Further information on the negotiation process is described in the tender documentation."
},
"submissionMethodDetails": "https://health-family.force.com/s/Welcome",
"submissionTerms": {
"electronicSubmissionPolicy": "allowed",
"languages": [
"en"
]
},
"tenderPeriod": {
"endDate": "2026-06-15T13:00:00+01:00"
},
"enquiryPeriod": {
"endDate": "2026-06-01T13:00:00+01:00"
},
"awardPeriod": {
"endDate": "2026-10-20T23:59:59+01:00"
},
"documents": [
{
"id": "conflictOfInterest",
"documentType": "conflictOfInterest"
},
{
"id": "043013-2026",
"documentType": "tenderNotice",
"noticeType": "UK4",
"description": "Tender notice on Find a Tender",
"url": "https://www.find-tender.service.gov.uk/Notice/043013-2026",
"datePublished": "2026-05-11T13:48:43+01:00",
"format": "text/html"
}
],
"hasRecurrence": true,
"recurrence": {
"dates": [
{
"startDate": "2026-10-20T23:59:59+01:00"
}
]
},
"riskDetails": "The below known unknown risks has been identified, which may require modification of the contract under paragraph 5 of Schedule 8 to the PA 2023 if one of the below identified risks materialise. Risk 1: The COVID-19 pandemic led to lockdown events, which disrupted the distribution and uptake of some national immunisation campaigns. The forecast delivery and stock requirements were substantially changed as a result. An ongoing risk is the materialisation of a UK health emergency or global pandemic, which may materialise in any given year. How the risk may impact on the performance of the contract: A health emergency or pandemic may materially affect the uptake of the product(s). Continued delivery of the product(s) within the original term of the contract could jeopardise stock management and effective use of product before expiry. Why is it not possible to address the potential impact of such risks? UKHSA and suppliers cannot reasonably predict the occurrence of a pandemic. UKHSA cannot determine an effective delivery schedule and contract term which would be effective during a pandemic to mitigate the risk of reduced uptake."
},
"language": "en"
}